CASE STUDIES

How we've helped

Early Stage companies.

Recon is not a place to bring your cookie-cutter assignments. We like to work on difficult strategy questions and each of our projects is bespoke. That said, we have the domain knowledge and process expertise that comes from having worked on hundreds of projects across all healthcare sectors.

Here is a sample of “sanitized” case examples.

Growth strategy for point-of-care testing

Post pandemic an innovative diagnostics platform company wanted to dramatically increase its market by targeting retail clinics for its point-of-care diagnostics platform

Growth, product market fit, value proposition

Device market entry strategy

An early-stage technology could digitize a large analog device market but needed the board aligned on which market to enter first, and on what terms to engage incumbents, before its Series A ran out.

Digital diagnostic business case

Biologics formulation platform diligence

A private equity investor weighing a bet on a novel delivery platform needed to know whether scientific novelty would convert into commercial value.

Subcutaneous biologics platform investment

Molecular diagnostics growth strategy

A molecular diagnostics developer had more new-test opportunities than it could fund and no shared view of which it was equipped to win or whether the economics could work.

New test portfolio prioritization

Gene therapy disease assessment

A gene therapy biotech with a novel approach to a fast-moving disease area needed an objective read on the opportunity and on whether it had a credible path to win there.

Crowded market entry decision

Strategy for digital behavioral health

Telehealth vendor threatened by AI

Telehealth, Digital, Mental Health